SCHEMBL28969587

SCHEMBL28969587

CONC(=O)c1ccc(Nc2ncc(C(=O)OC)c(Nc3ccccc3P(C)(C)=O)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 18/20 0.54
AURKA O14965 2/20 0.46
JAK2 O60674 1/20 0.46
NTRK1 P04629 1/20 0.46
TYK2 P29597 1/20 0.46
KDR P35968 1/20 0.46
JAK3 P52333 1/20 0.46
PTK2B Q14289 1/20 0.46
NTRK3 Q16288 1/20 0.46
NTRK2 Q16620 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28969639 0.93 PTK2 (0.54) PTK2AURKA
SCHEMBL30184426 0.93 PTK2 (0.54) PTK2AURKA
SCHEMBL24752245 0.92 PTK2 (0.57) PTK2JAK2NTRK1TYK2KDR
SCHEMBL30002235 0.92 PTK2 (0.57) PTK2JAK2NTRK1TYK2KDR
SCHEMBL28969593 0.90 AURKA (0.57) PTK2AURKAJAK2NTRK2
SCHEMBL24752251 0.90 PTK2 (0.55) PTK2NTRK2
SCHEMBL30002994 0.90 PTK2 (0.55) PTK2NTRK2
SCHEMBL24752249 0.88 AURKA (0.58) PTK2AURKAJAK2
SCHEMBL24752678 0.88 PTK2 (0.69) PTK2
SCHEMBL30184428 0.88 AURKA (0.58) PTK2AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116870016-B Heteroaromatic compound and medical application thereof 希格生科(深圳)有限公司 2024-05-28 CN disclosed
CN-117412981-A Phosphine oxide derivative and preparation method and application thereof 希格生科(深圳)有限公司 2024-01-16 CN disclosed
CN-116870016-A Heteroaromatic compound and medical application thereof 希格生科(深圳)有限公司 2023-10-13 CN disclosed
CN-115785154-A Heteroaromatic ring compounds and medical use thereof 希格生科(深圳)有限公司 2023-03-14 CN disclosed